3D Systems sells Simbionix medical simulation business to Surgical Science for $305M

3D Systems has signed a definitive agreement to sell its medical simulation business, Simbionix, to Surgical Science Sweden AB for $305 million. The divestiture completes 3D Systems' initiative to focus on additive manufacturing.

“3D Systems today announced it has signed a definitive agreement to sell its medical simulation business, Simbionix, to Surgical Science Sweden AB for a purchase price of $305 million.”investor.3dsystems.com

• 3 sources
• investor.3dsystems.com3D Systems, Inc. - 3D Systems Announces Sale of Medical Simulation Business - SimbionixJul 28, 2021
• view.news.eu.nasdaq.comSurgical Science has entered into an agreement to acquire SimbionixJul 28, 2021
• investor.3dsystems.com3D Systems, Inc. - 3D Systems to Drive Adoption of Additive Manufacturing in Production Environments with the Acquisition of OqtonSep 8, 2021

Summarized from public sources; check the original articles before acting on it.